Literature DB >> 3360686

Synergy between clavulanic acid and newer beta-lactams on nine clinical isolates of Klebsiella pneumoniae, Escherichia coli and Salmonella typhimurium resistant to third-generation cephalosporins.

S Ben Redjeb, H Ben Yaghlane, A Boujnah, A Philippon, R Labia.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3360686     DOI: 10.1093/jac/21.2.263

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  19 in total

1.  Epidemiology of extended spectrum beta-lactamases.

Authors:  A Philippon; S Ben Redjeb; G Fournier; A Ben Hassen
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

2.  Identification of CTX-2, a novel cefotaximase from a Salmonella mbandaka isolate.

Authors:  M C Poupart; C Chanal; D Sirot; R Labia; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

3.  Detection of extended broad-spectrum beta-lactamases in Enterobacteriaceae in four French hospitals.

Authors:  P Legrand; G Fournier; A Buré; V Jarlier; M H Nicolas; D Decré; J Duval; A Philippon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-06       Impact factor: 3.267

Review 4.  Extended-spectrum beta-lactamases.

Authors:  A Philippon; R Labia; G Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

5.  Pork meat as a potential source of Salmonella enterica subsp. arizonae infection in humans.

Authors:  Grammato Evangelopoulou; Spyridon Kritas; Alexander Govaris; Angeliki R Burriel
Journal:  J Clin Microbiol       Date:  2013-12-11       Impact factor: 5.948

6.  New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak.

Authors:  M I Morosini; R Canton; J Martinez-Beltran; M C Negri; J C Perez-Diaz; F Baquero; J Blazquez
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

7.  In vivo acquisition of extended-spectrum beta-lactamase in Salmonella enteritidis during antimicrobial therapy.

Authors:  F Barguellil; C Burucoa; A Amor; J L Fauchère; C Fendri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-08       Impact factor: 3.267

8.  Distribution of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in Vietnam.

Authors:  Van Cao; Thierry Lambert; Duong Quynh Nhu; Huynh Kim Loan; Nguyen Kim Hoang; Guillaume Arlet; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

9.  Characterization of the first extended-spectrum beta-lactamase-producing Salmonella isolate identified in Canada.

Authors:  Michael R Mulvey; Geoff Soule; David Boyd; Walter Demczuk; Rafiq Ahmed
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

Review 10.  [Evaluation of the development of resistance as a factor for the limitation of therapeutic possibilities].

Authors:  P Heisig; B Wiedemann
Journal:  Infection       Date:  1991       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.